Lennie Ryer

Lennie Ryer

Director/Board Member at PHARMALA BIOTECH HOLDINGS INC.

Net worth: 5 832 $ as of 31/08/2026

66 year
Health Technology
Commercial Services
Consumer Services

Profile

Lennie Ryer is currently Director at Aegera Therapeutics, Inc., Director at Pharmala Biotech Holdings, Inc. starting in 2026, and Member at Canadian Tax Foundation.
Former positions include Director at BANGI, Inc. from 2007 to 2008; Chief Financial Officer & Vice President-Finance at Paladin Labs, Inc. from 1999 to 2001; Chief Financial Officer & Vice President-Finance at ConjuChem Biotechnologies, Inc. from 2001 to 2009; Managing Partner at BDO Dunwoody LLP; CFO & Investor Relations Contact at SQI Diagnostics, Inc. from 2015 to 2016; Chief Financial Officer at Les Équipements Power Survey Ltée from 2016 to 2017; Chief Financial Officer at Meteorite Capital, Inc.; Chief Financial Officer & Vice President at Cannara Biotech, Inc.; and Chief Financial Officer at Group JS International Ltd. from 2013 to 2015.
Education includes undergraduate studies at McGill University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/05/2026 36,000 ( 0.03% ) 5 832 $ 31/08/2026

Lennie Ryer active positions

CompaniesPositionStart
PHARMALA BIOTECH HOLDINGS INC. Director/Board Member 09/02/2026
Director/Board Member -
Corporate Officer/Principal -

Former positions of Lennie Ryer

CompaniesPositionEnd
CANNARA BIOTECH INC. Director of Finance/CFO 05/11/2020
Director of Finance/CFO 01/10/2017
SQI DIAGNOSTICS INC. Director of Finance/CFO 15/02/2016
Director of Finance/CFO 01/02/2015
Director of Finance/CFO 31/08/2009
See the detail of Lennie Ryer's experience

Training of Lennie Ryer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Miscellaneous

Electronic Technology

Finance

Process Industries

Consumer Non-Durables

Health Technology